152 related articles for article (PubMed ID: 9048213)
21. D6S273 microsatellite polymorphism and susceptibility to rheumatoid arthritis.
Singal DP; Li J; Ye M; Lei K
Tissue Antigens; 1998 Oct; 52(4):353-8. PubMed ID: 9820598
[TBL] [Abstract][Full Text] [Related]
22. Major differences in antigen-processing correlate with a single Arg71<-->Lys substitution in HLA-DR molecules predisposing to rheumatoid arthritis and with their selective interactions with 70-kDa heat shock protein chaperones.
Roth S; Willcox N; Rzepka R; Mayer MP; Melchers I
J Immunol; 2002 Sep; 169(6):3015-20. PubMed ID: 12218116
[TBL] [Abstract][Full Text] [Related]
23. Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis.
Gonzalez-Gay MA; Garcia-Porrua C; Hajeer AH
Semin Arthritis Rheum; 2002 Jun; 31(6):355-60. PubMed ID: 12077707
[TBL] [Abstract][Full Text] [Related]
24. HLA-DR4, 70 kD heat shock proteins, and rheumatoid arthritis.
Auger I; Roudier J
Rev Rhum Engl Ed; 1997 Mar; 64(3):141-4. PubMed ID: 9090759
[No Abstract] [Full Text] [Related]
25. Complementation between HLA-DR4 (DRB1*0401) and specific H2-A molecule in transgenic mice leads to collagen-induced arthritis.
Pan S; Taneja V; Griffiths MM; Luthra H; David CS
Hum Immunol; 1999 Sep; 60(9):816-25. PubMed ID: 10527388
[TBL] [Abstract][Full Text] [Related]
26. Protection against rheumatoid arthritis by HLA: nature and nurture.
Feitsma AL; van der Helm-van Mil AH; Huizinga TW; de Vries RR; Toes RE
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii61-3. PubMed ID: 19022816
[TBL] [Abstract][Full Text] [Related]
27. DQCAR microsatellite polymorphism and susceptibility to rheumatoid arthritis.
Singal DP; Li J; Ye M
Tissue Antigens; 1998 Jun; 51(6):613-7. PubMed ID: 9694353
[TBL] [Abstract][Full Text] [Related]
28. A distinctive peptide binding motif for HLA-DRB1*0407, an HLA-DR4 subtype not associated with rheumatoid arthritis.
Davenport MP; Godkin A; Friede T; Stevanović S; Willis AC; Hill AV; Rammensee HG
Immunogenetics; 1997; 45(3):229-32. PubMed ID: 8995193
[No Abstract] [Full Text] [Related]
29. Association of specific amino acid sequence of HLA-DR with rheumatoid arthritis in Koreans and its diagnostic value.
Hong GH; Park MH; Takeuchi F; Oh MD; Song YW; Nabeta H; Nakano K; Ito K; Park KS
J Rheumatol; 1996 Oct; 23(10):1699-703. PubMed ID: 8895143
[TBL] [Abstract][Full Text] [Related]
30. HLA class III region and susceptibility to rheumatoid arthritis.
Singal DP; Li J; Zhu Y
Clin Exp Rheumatol; 2000; 18(4):485-91. PubMed ID: 10949724
[TBL] [Abstract][Full Text] [Related]
31. Use of T cell receptor/HLA-DRB1*04 molecular modeling to predict site-specific interactions for the DR shared epitope associated with rheumatoid arthritis.
Penzotti JE; Nepom GT; Lybrand TP
Arthritis Rheum; 1997 Jul; 40(7):1316-26. PubMed ID: 9214433
[TBL] [Abstract][Full Text] [Related]
32. Examination of HLA-DR4 as a severity marker for rheumatoid arthritis in Greek patients.
Boki KA; Drosos AA; Tzioufas AG; Lanchbury JS; Panayi GS; Moutsopoulos HM
Ann Rheum Dis; 1993 Jul; 52(7):517-9. PubMed ID: 8102226
[TBL] [Abstract][Full Text] [Related]
33. Expression of QK/QR/RRRAA or DERAA motifs at the third hypervariable region of HLA-DRB1 and disease severity in rheumatoid arthritis.
Khani-Hanjani A; Lacaille D; Horne C; Chalmers A; Hoar DI; Balshaw R; Keown PA
J Rheumatol; 2002 Jul; 29(7):1358-65. PubMed ID: 12136889
[TBL] [Abstract][Full Text] [Related]
34. Tolerance to a self-peptide from the third hypervariable region of HLA DRB1*0401 in rheumatoid arthritis patients and normal subjects.
Salvat S; Auger I; Rochelle L; Begovich A; Geburher L; Sette A; Roudier J
J Immunol; 1994 Dec; 153(11):5321-9. PubMed ID: 7963584
[TBL] [Abstract][Full Text] [Related]
35. HLA-DRB1 gene sequences in HLA-DR4 positive and negative patients with rheumatoid arthritis.
Becking A; Pluschke G; Krawinkel U; Melchers I; Peter HH; Lang B
Eur J Immunogenet; 1993 Apr; 20(2):83-9. PubMed ID: 8494871
[TBL] [Abstract][Full Text] [Related]
36. HLA-DRB1 and anti-cyclic citrullinated peptide antibody production in rheumatoid arthritis.
Senkpiehl I; Marget M; Wedler M; Jenisch S; Georgi J; Kabelitz D; Steinmann J
Int Arch Allergy Immunol; 2005 Aug; 137(4):315-8. PubMed ID: 15970640
[TBL] [Abstract][Full Text] [Related]
37. DR4Dw4/DR53 molecules contain a peptide from the autoantigen calreticulin.
Verreck FA; Elferink D; Vermeulen CJ; Amons R; Breedveld F; de Vries RR; Koning F
Tissue Antigens; 1995 Apr; 45(4):270-5. PubMed ID: 7638864
[TBL] [Abstract][Full Text] [Related]
38. Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401).
Rosloniec EF; Whittington KB; He X; Stuart JM; Kang AH
Am J Med Sci; 2004 Apr; 327(4):169-79. PubMed ID: 15084912
[TBL] [Abstract][Full Text] [Related]
39. Endogenous HLA-DR-restricted presentation of the cartilage antigens human cartilage gp-39 and melanoma inhibitory activity in the inflamed rheumatoid joint.
van Lierop MJ; den Hoed L; Houbiers J; Vencovsky J; Ruzickova S; Krystufkova O; van Schaardenburg M; van den Hoogen F; Vandooren B; Baeten D; De Keyser F; Sønderstrup G; Bos E; Boots AM
Arthritis Rheum; 2007 Jul; 56(7):2150-9. PubMed ID: 17599744
[TBL] [Abstract][Full Text] [Related]
40. Genetics of rheumatoid arthritis (RA): two separate regions in the major histocompatibility complex contribute to susceptibility to RA.
Singal DP; Li J; Lei K
Immunol Lett; 1999 Sep; 69(3):301-6. PubMed ID: 10528792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
